Cargando…

Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up

OBJECTIVE: This pilot study evaluates the pressure lowering potential of subthreshold micropulse diode laser trabeculoplasty (MDLT) for a clinically meaningful duration in patients with medically uncontrolled open angle glaucoma (OAG). DESIGN: prospective interventional case series. PARTICIPANTS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fea, Antonio Maria, Bosone, Alex, Rolle, Teresa, Brogliatti, Beatrice, Grignolo, Federico Maria
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693967/
https://www.ncbi.nlm.nih.gov/pubmed/19668712
_version_ 1782168025575718912
author Fea, Antonio Maria
Bosone, Alex
Rolle, Teresa
Brogliatti, Beatrice
Grignolo, Federico Maria
author_facet Fea, Antonio Maria
Bosone, Alex
Rolle, Teresa
Brogliatti, Beatrice
Grignolo, Federico Maria
author_sort Fea, Antonio Maria
collection PubMed
description OBJECTIVE: This pilot study evaluates the pressure lowering potential of subthreshold micropulse diode laser trabeculoplasty (MDLT) for a clinically meaningful duration in patients with medically uncontrolled open angle glaucoma (OAG). DESIGN: prospective interventional case series. PARTICIPANTS: Thirty-two eyes of 20 consecutive patients with uncontrolled OAG (12 bilateral and 8 unilateral). METHODS: Confluent subthreshold laser applications over the inferior 180° of the anterior TM using an 810 nm diode laser in a micropulse operating mode. The intraocular pressure (IOP) was measured at baseline and at 1 hour, 1 day, 1 week, 3, 6, 9, and 12 months post-treatment. Flare was measured with a Kowa FM 500 flare-meter at baseline and at 3 hours, 1 day, 1 week, and 12 months post-treatment. After treatment, the patients were maintained on their pre-treatment drug regimen. MAIN OUTCOME MEASURES: Criteria for treatment response were IOP reduction ≥3 mm Hg and IOP ≤21 mm Hg within the first week after MDLT. Eyes not complying to the above criteria during the follow-up were considered treatment failure. Mean IOP change and percentage of IOP reduction during the follow-up were calculated. RESULTS: One eye was analyzed for bilateral patients. A total of 20 eyes were thus included. Four eyes (20%) did not respond to treatment during the first week. One additional eye failed at the 6 month visit. The treatment was successful in 15 eyes (75%) at 12 months. The IOP was significantly lower throughout follow-up (p < 0.01). At 12 months, the mean percentage of IOP reduction in the 15 respondent eyes was 22.1% and 12 eyes (60%) had IOP reduction higher than 20%. During the first two postoperative days, one eye with pigmentary glaucoma experienced a significant increase of flare associated with an IOP spike (34 mm Hg) that was controlled with systemic drugs; afterwards it qualified as a respondent and completed the study. No increase of flare was found in any other patient. No peripheral anterior synechiae formed. CONCLUSIONS: In this case series, MDLT was effective in reducing IOP in 75% of medically insufficiently controlled OAG eyes without significant complications. This justifies randomized clinical studies to compare MDLT with current IOP lowering strategies.
format Text
id pubmed-2693967
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26939672009-08-10 Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up Fea, Antonio Maria Bosone, Alex Rolle, Teresa Brogliatti, Beatrice Grignolo, Federico Maria Clin Ophthalmol Original Research OBJECTIVE: This pilot study evaluates the pressure lowering potential of subthreshold micropulse diode laser trabeculoplasty (MDLT) for a clinically meaningful duration in patients with medically uncontrolled open angle glaucoma (OAG). DESIGN: prospective interventional case series. PARTICIPANTS: Thirty-two eyes of 20 consecutive patients with uncontrolled OAG (12 bilateral and 8 unilateral). METHODS: Confluent subthreshold laser applications over the inferior 180° of the anterior TM using an 810 nm diode laser in a micropulse operating mode. The intraocular pressure (IOP) was measured at baseline and at 1 hour, 1 day, 1 week, 3, 6, 9, and 12 months post-treatment. Flare was measured with a Kowa FM 500 flare-meter at baseline and at 3 hours, 1 day, 1 week, and 12 months post-treatment. After treatment, the patients were maintained on their pre-treatment drug regimen. MAIN OUTCOME MEASURES: Criteria for treatment response were IOP reduction ≥3 mm Hg and IOP ≤21 mm Hg within the first week after MDLT. Eyes not complying to the above criteria during the follow-up were considered treatment failure. Mean IOP change and percentage of IOP reduction during the follow-up were calculated. RESULTS: One eye was analyzed for bilateral patients. A total of 20 eyes were thus included. Four eyes (20%) did not respond to treatment during the first week. One additional eye failed at the 6 month visit. The treatment was successful in 15 eyes (75%) at 12 months. The IOP was significantly lower throughout follow-up (p < 0.01). At 12 months, the mean percentage of IOP reduction in the 15 respondent eyes was 22.1% and 12 eyes (60%) had IOP reduction higher than 20%. During the first two postoperative days, one eye with pigmentary glaucoma experienced a significant increase of flare associated with an IOP spike (34 mm Hg) that was controlled with systemic drugs; afterwards it qualified as a respondent and completed the study. No increase of flare was found in any other patient. No peripheral anterior synechiae formed. CONCLUSIONS: In this case series, MDLT was effective in reducing IOP in 75% of medically insufficiently controlled OAG eyes without significant complications. This justifies randomized clinical studies to compare MDLT with current IOP lowering strategies. Dove Medical Press 2008-06 /pmc/articles/PMC2693967/ /pubmed/19668712 Text en © 2008 Fea et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Fea, Antonio Maria
Bosone, Alex
Rolle, Teresa
Brogliatti, Beatrice
Grignolo, Federico Maria
Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
title Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
title_full Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
title_fullStr Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
title_full_unstemmed Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
title_short Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
title_sort micropulse diode laser trabeculoplasty (mdlt): a phase ii clinical study with 12 months follow-up
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693967/
https://www.ncbi.nlm.nih.gov/pubmed/19668712
work_keys_str_mv AT feaantoniomaria micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup
AT bosonealex micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup
AT rolleteresa micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup
AT brogliattibeatrice micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup
AT grignolofedericomaria micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup